Drug
Bexmarilimab
Bexmarilimab: highest development phase Phase 2, developed by Faron Pharmaceuticals Ltd. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Faron Pharmaceuticals Ltd
Trials
| Drug | Phase | Indication |
|---|---|---|
| bexmarilimab (1mg/kg) NCT07672769 | Phase 2 | Higher Risk Myelodysplastic Syndromes |
Latest
No recent events.
Follow Bexmarilimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.